Axon Enterprise, INC Form 4 insider transactions

NASDAQ
Director Matthew McBrady acquired 657 shares of Axon Enterprise, Inc. common stock on May 10, 2024.
NASDAQ
Director Graham Smith acquired 657 shares of Axon Enterprise common stock through time-vested restricted stock units.
NASDAQ
Director Hadi Partovi reports acquiring 657 shares of Axon Enterprise common stock through time-vested restricted stock units.
NASDAQ
Director Erika Nardini acquired 657 shares of Axon Enterprise common stock in the form of restricted stock units, vesting fully by the company's 2025 annual meeting.
NASDAQ
Director Jeri Williams reports a sale of 308 shares and acquisition of 657 restricted stock units of Axon Enterprise stock.
NASDAQ
Jeffrey Kunins, CPO & CTO of Axon Enterprise, executed multiple sales of common stock on May 9, 2024, at prices ranging from $308.81 to $312.7850.
NASDAQ
Axon Enterprise's President, Joshua Isner, executed multiple sales of common stock on May 9, 2024, at prices ranging from $307.80 to $312.73.
NASDAQ
Cameron Brooks, Chief Revenue Officer of Axon Enterprise, Inc., reports the acquisition of 23,715 restricted stock units.
NASDAQ
Brittany Bagley, COO & CFO of Axon Enterprise, disposed of shares to cover tax liabilities from vesting restricted stock units.
NASDAQ
Brittany Bagley, COO & CFO of Axon Enterprise, reports the acquisition of 3,213 restricted stock units that will vest on September 7, 2024.
NASDAQ
Joshua Isner, President of Axon Enterprise, reports acquiring 10,279 shares of common stock on March 14, 2024, through time-vested restricted stock units.
NASDAQ
Jeffrey Kunins, CPO & CTO of Axon Enterprise, reports the acquisition of 2,185 restricted stock units that will vest on September 7, 2024.